Juan Graham is a distinguished finance executive with more than 25 years of experience in the biotechnology and healthcare sectors. Holding a Bachelor’s degree in Accounting from Stanford University and an MBA from the Wharton School of the University of Pennsylvania, Graham began his career at Ernst & Young, where he honed his expertise in financial auditing and advisory services for life sciences firms. He progressed through leadership roles at biotech powerhouses such as Gilead Sciences and BioMarin Pharmaceutical, managing financial operations, strategic planning, and capital raises that fueled product development and market expansions. As Chief Financial Officer at Perspective Therapeutics Inc., Graham was instrumental in navigating the company through a period of rapid innovation and growth in radiopharmaceutical therapies for cancer treatment. He orchestrated over $200 million in financing through public offerings, venture capital, and strategic partnerships, while optimizing operational efficiencies that improved the company's cash position and supported pivotal clinical advancements, including Phase 2 and Phase 3 trials for lead candidates. His leadership ensured robust financial compliance, investor confidence, and alignment with FDA regulatory milestones, positioning Perspective Therapeutics as a frontrunner in precision oncology. Since stepping down as CFO, Graham has transitioned into advisory roles for emerging biotech ventures and serves on the boards of several oncology-focused organizations. His track record of delivering sustainable growth and value creation continues to influence the industry, earning him recognition from outlets like BioSpace and Fierce Biotech for his strategic acumen.